(Q43638380)

25 November 2017

Levetiracetam inhibits the high-voltage-activated Ca(2+) current in pyramidal neurones of rat hippocampal slices (English)

1 reference

25 November 2017

0 references

1 reference

Niespodziany I

1

1 reference

25 November 2017

Klitgaard H

series ordinal

2

1 reference

25 November 2017

Margineanu DG

series ordinal

3

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

25 November 2017

1 reference

25 November 2017

306

1 reference

25 November 2017

1-2

1 reference

25 November 2017

5-8

1 reference

Carbamazepine inhibits L-type Ca2+ channels in cultured rat hippocampal neurons stimulated with glutamate receptor agonists.

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901884-5

7 January 2021

Levetiracetam (ucb LO59) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901884-5

7 January 2021

Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901884-5

7 January 2021

Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901884-5

7 January 2021

Development of HVA and LVA calcium currents in pyramidal CA1 neurons in the hippocampus of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901884-5

7 January 2021

Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901884-5

7 January 2021

Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901884-5

7 January 2021

Inhibition by levetiracetam of a non-GABAA receptor-associated epileptiform effect of bicuculline in rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901884-5

7 January 2021

The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901884-5

7 January 2021

Pharmacokinetic profile of levetiracetam: toward ideal characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901884-5

7 January 2021

Effects of carbamazepine on membrane properties of rat sensory spinal ganglion cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901884-5

7 January 2021

Voltage-activated calcium channels: targets of antiepileptic drug therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901884-5

7 January 2021

Gabapentin inhibits calcium currents in isolated rat brain neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901884-5

7 January 2021

Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901884-5

7 January 2021

Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901884-5

7 January 2021

Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca2+ currents

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901884-5

7 January 2021

10.1016/S0304-3940(01)01884-5

Identifiers

DOI

1 reference

25 November 2017

1 reference